We evaluated retrospectively the clinical outcome of 47 patients with acute myelogenous leukemia who entered an intensive chemoimmunotherapy treatment protocol between January 1975 and July 1978. Remission duration and survival were substantially longer in patients in whom hepatitis developed.
(JAMA 244:1806-1807, 1980)
Foon KA, Yale C, Clodfelter K, Gale RP. Posttransfusion Hepatitis in Acute Myelogenous Leukemia: Effect on Survival. JAMA. 1980;244(16):1806–1807. doi:10.1001/jama.1980.03310160022017
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: